Cerium Pharmaceuticals
Gaithersburg, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into Cerium Pharmaceuticals
47 people in our graph share verified history with the Cerium Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Diana Bernsteinunlockedknows Nancy Klett · together at Sigma-Tau Pharmaceuticals, Inc. (overlapped)
×10knows the team · via The George Washington University
knows the team · via The George Washington University School of Medicine and Health Sciences
Cerium Pharmaceuticals develops and commercializes medicines for rare or "orphan" diseases, including kidney disease. The company operates in the biopharmaceutical industry with a focus on the rare disease community.
Founders & leadership
Cerium Pharmaceuticals was founded in 2012 by Gregg Lapointe, Robert J. Rubin, and Nancy Klett.
GL
Gregg LapointeinCo-founder · Chief Executive Officer
RJ
Robert J. RubinCo-Founder & Interim CMO
NK
Nancy KlettinCo-Founder & Chief Operating OfficerShe has held roles in human resources and project management, with experience in employee relations, workforce planning, training and development, and compensation and benefits administration.
ŞB
Şemsi Burak DerkuntinChief Scientific Officer
BS
Brian SchreiberinChief Medical Officer (2015 to 2021)
PC
Peter CollumNamed on SEC filing
SE
Steve EskenaziNamed on SEC filing
TD
Tom DePasqualeNamed on SEC filing
Board
JG
Investors · 1
Reported raises · per SEC filings
Form D private placements$13.8M disclosed across 4 rounds · 2016–2026
▶$750KraisedAug 2026 · 4 investors · PharmaceuticalsRule 506(b)
▶$750KraisedAug 2026 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gregg A. LapointeExecutive Officer, Director
- Peter CollumDirector
- Steve EskenaziDirector
- Robert RubinDirector
- Tom DePasqualeDirector
- James GaleDirector
- Offering amount
- $2.5M
- Amount sold
- $750K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.9MraisedJul 2021 · 5 investors · BiotechnologyRule 506(b)
▶$8.9MraisedJul 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James GaleDirector
- Gregg LapointeExecutive Officer, Director
- Nancy KlettExecutive Officer
- Thomas A DePasqualeDirector
- Offering amount
- $10.1M
- Amount sold
- $8.9M
- Minimum investment
- $25K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedMay 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1.9MraisedMay 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregg LapointeExecutive Officer, Director
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- Minimum investment
- $25K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedJun 2016 · 9 investors · BiotechnologyRule 506(c)
▶$2.3MraisedJun 2016 · 9 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Gregg LapointeExecutive Officer, Director
- Offering amount
- $7.3M
- Amount sold
- $2.3M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Collegium Pharmaceutical26 shared keywordsCollegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.
Catalent17 shared keywordsCatalent is a global Contract Development and Manufacturing Organization (CDMO) that helps pharma, biotech, and self-care companies develop, manufacture, and deliver drug products and consumer health solutions. Its services span oral dose, biologics, specialty, and clinical supply, from early-stage design through commercial manufacturing.
Inven14 shared keywordsInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.
Companies competing with Cerium Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Cerium Pharmaceuticals do?
- Cerium Pharmaceuticals develops and commercializes medicines for rare or "orphan" diseases, including kidney disease. The company operates in the biopharmaceutical industry with a focus on the rare disease community.
- Who founded Cerium Pharmaceuticals?
- Cerium Pharmaceuticals was founded by Gregg Lapointe, Robert J. Rubin, Nancy Klett in 2012.
- Who are Cerium Pharmaceuticals's investors?
- Cerium Pharmaceuticals's investors include Signet Healthcare Partners.
- How much funding has Cerium Pharmaceuticals raised?
- Cerium Pharmaceuticals has disclosed $13.8M raised across 4 rounds.
- Where is Cerium Pharmaceuticals headquartered?
- Cerium Pharmaceuticals is headquartered in Gaithersburg, US.